Sana class action alert: shareholder rights law firm robbins llp reminds investors of the lead plaintiff deadline in the sana biotechnology, inc. class action

San diego, ca / access newswire / march 31, 2025 / robbins llp reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired sana biotechnology, inc. (nasdaq:sana) securities between march 17, 2023 and november 4, 2024. sana is a biotechnology company that develops ex vivo and in vivo cell engineering programs to purportedly revolutionize treatment across a broad array of therapeutic areas with unmet treatment needs, including, inter alia, oncology, diabetes, central nervous system ("cns") disorders, and b-cell-mediated autoimmune diseases.
SANA Ratings Summary
SANA Quant Ranking